RIGEL PHARMACEUTICALS, INC. Earnings Per Share (Basic)
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Earnings Per Share (Basic) of $0.93 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- RIGEL PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was $0.93, a 72.07% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was $0.47, a 26.56% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-12-31 was $14.72, a 1711.33% increase year-over-year.
- RIGEL PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was $1.55, a 118.31% increase year-over-year.
- RIGEL PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was $20.40, a 1960.61% increase from fiscal 2024.
- RIGEL PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was $0.99.
- RIGEL PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$1.44.
- RIGEL PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$3.44.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.93 10-Q · filed 2026-08-04 | $1.40 10-Q · filed 2026-08-04 | ||||||
| 2026-03-31 | $0.47 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | $14.72 derived: net income ÷ weighted average shares · filed 2026-03-03 | $16.33 derived: net income ÷ weighted average shares · filed 2026-03-03 | $19.71 derived: net income ÷ weighted average shares · filed 2026-08-04 | $20.40 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $1.55 10-Q · filed 2025-11-04 | $4.87 derived: net income ÷ weighted average shares · filed 2026-08-04 | $5.52 10-Q · filed 2025-11-04 | $6.35 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2025-06-30 | $3.33 10-Q · filed 2026-08-04 | $3.98 10-Q · filed 2026-08-04 | $4.80 derived: net income ÷ weighted average shares · filed 2026-08-04 | $5.52 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2025-03-31 | $0.64 10-Q · filed 2026-05-05 | $1.45 derived: net income ÷ weighted average shares · filed 2026-05-05 | $2.16 derived: net income ÷ weighted average shares · filed 2026-05-05 | $2.11 derived: net income ÷ weighted average shares · filed 2026-05-05 | ||||
| 2024-12-31 | $0.81 derived: net income ÷ weighted average shares · filed 2026-03-03 | $1.52 derived: net income ÷ weighted average shares · filed 2026-03-03 | $1.46 derived: net income ÷ weighted average shares · filed 2026-03-03 | $0.99 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $0.71 10-Q · filed 2025-11-04 | $0.65 derived: net income ÷ weighted average shares · filed 2025-11-04 | $0.18 10-Q · filed 2025-11-04 | $0.22 derived: net income ÷ weighted average shares · filed 2026-03-03 | ||||
| 2024-06-30 | -$0.06 10-Q · filed 2025-08-05 | -$0.53 10-Q · filed 2025-08-05 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-03-03 | ||||
| 2024-03-31 | -$0.47 10-Q · filed 2025-05-06 | -$0.05 10-Q · filed 2024-05-07 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-03-03 | |||
| 2023-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$1.44 10-K · filed 2026-03-03 | -$0.14 10-K · filed 2024-03-05 | |||
| 2023-09-30 | -$0.33 10-Q · filed 2024-11-07 | -$0.03 10-Q · filed 2023-11-07 | -$0.71 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.49 10-Q · filed 2024-11-07 | -$0.15 10-Q · filed 2023-11-07 | $0.41 derived: net income ÷ weighted average shares · filed 2025-03-04 | ||
| 2023-06-30 | -$0.38 10-Q · filed 2024-08-06 | -$0.04 10-Q · filed 2023-08-01 | -$1.16 10-Q · filed 2024-08-06 | -$0.12 10-Q · filed 2023-08-01 | $0.22 derived: net income ÷ weighted average shares · filed 2025-03-04 | $1.78 derived: net income ÷ weighted average shares · filed 2025-03-04 | ||
| 2023-03-31 | -$0.08 10-Q · filed 2024-05-07 | $0.09 derived: net income ÷ weighted average shares · filed 2025-03-04 | $0.92 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$2.55 derived: net income ÷ weighted average shares · filed 2025-03-04 | ||||
| 2022-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-03-04 | $0.13 derived: net income ÷ weighted average shares · filed 2025-03-04 | $0.90 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$3.44 10-K · filed 2025-03-04 | -$0.34 10-K · filed 2023-03-07 | |||
| 2022-09-30 | -$0.11 10-Q · filed 2023-11-07 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.35 10-Q · filed 2023-11-07 | -$0.48 derived: net income ÷ weighted average shares · filed 2024-03-05 | ||||
| 2022-06-30 | -$0.08 10-Q · filed 2023-08-01 | -$0.24 10-Q · filed 2023-08-01 | -$0.37 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$0.49 derived: net income ÷ weighted average shares · filed 2024-03-05 | ||||
| 2022-03-31 | -$0.16 10-Q · filed 2023-05-02 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$0.41 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$0.50 derived: net income ÷ weighted average shares · filed 2024-03-05 | ||||
| 2021-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$0.25 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$0.34 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$0.11 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | -$0.12 10-Q · filed 2022-11-03 | -$0.20 derived: net income ÷ weighted average shares · filed 2022-11-03 | $0.03 10-Q · filed 2022-11-03 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-11-03 | ||||
| 2021-06-30 | -$0.08 10-Q · filed 2022-08-02 | $0.15 10-Q · filed 2022-08-02 | $0.04 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.05 derived: net income ÷ weighted average shares · filed 2022-11-03 | ||||
| 2021-03-31 | $0.23 10-Q · filed 2022-05-03 | $0.12 derived: net income ÷ weighted average shares · filed 2022-11-03 | $0.04 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.07 derived: net income ÷ weighted average shares · filed 2022-11-03 | ||||
| 2020-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.20 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$0.30 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$0.18 10-K · filed 2023-03-07 | ||||
| 2020-09-30 | -$0.08 10-Q · filed 2021-11-02 | -$0.19 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$0.06 10-Q · filed 2021-11-02 | -$0.16 derived: net income ÷ weighted average shares · filed 2021-11-02 | ||||
| 2020-06-30 | -$0.10 10-Q · filed 2021-08-03 | $0.02 10-Q · filed 2021-08-03 | -$0.08 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$0.15 derived: net income ÷ weighted average shares · filed 2021-11-02 | ||||
| 2020-03-31 | $0.13 10-Q · filed 2021-05-05 | $0.02 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$0.04 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$0.17 derived: net income ÷ weighted average shares · filed 2021-11-02 | ||||
| 2019-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.17 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.29 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.40 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$0.07 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.19 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.30 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.28 derived: net income ÷ weighted average shares · filed 2021-03-02 | ||||
| 2019-06-30 | -$0.12 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.23 derived: net income ÷ weighted average shares · filed 2020-08-04 | -$0.21 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-03-02 | ||||
| 2019-03-31 | -$0.11 10-Q · filed 2020-05-05 | -$0.09 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.23 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.38 derived: net income ÷ weighted average shares · filed 2021-03-02 | ||||
| 2018-12-31 | $0.02 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.12 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.28 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.44 derived: net income ÷ weighted average shares · filed 2021-03-02 | ||||
| 2018-09-30 | -$0.14 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.30 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.47 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.64 derived: net income ÷ weighted average shares · filed 2020-02-27 | ||||
| 2018-06-30 | -$0.16 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.32 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.50 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.65 derived: net income ÷ weighted average shares · filed 2020-02-27 | ||||
| 2018-03-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.34 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.49 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.65 derived: net income ÷ weighted average shares · filed 2020-02-27 | ||||
| 2017-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.32 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.48 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.62 derived: net income ÷ weighted average shares · filed 2020-02-27 | ||||
| 2017-09-30 | -$0.14 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.30 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.43 derived: net income ÷ weighted average shares · filed 2019-02-28 | |||||
| 2017-06-30 | -$0.16 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.29 derived: net income ÷ weighted average shares · filed 2019-02-28 | ||||||
| 2017-03-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2019-02-28 | |||||||
| 2014-12-31 | -$1.04 derived: net income ÷ weighted average shares · filed 2017-03-07 | |||||||
| 2013-12-31 | -$1.02 derived: net income ÷ weighted average shares · filed 2016-03-08 | |||||||
| 2012-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2015-03-03 | -$0.65 derived: net income ÷ weighted average shares · filed 2015-03-03 | -$0.99 derived: net income ÷ weighted average shares · filed 2015-03-03 | -$1.32 10-K · filed 2013-03-05 | ||||
| 2012-09-30 | -$0.36 10-Q · filed 2012-11-06 | -$0.70 derived: net income ÷ weighted average shares · filed 2014-03-04 | -$1.03 10-Q · filed 2012-11-06 | -$1.39 derived: net income ÷ weighted average shares · filed 2014-03-04 | ||||
| 2012-06-30 | -$0.35 10-Q · filed 2012-08-07 | -$0.67 10-Q · filed 2012-08-07 | -$1.03 derived: net income ÷ weighted average shares · filed 2014-03-04 | -$1.28 derived: net income ÷ weighted average shares · filed 2014-03-04 | ||||
| 2012-03-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2014-03-04 | -$0.69 derived: net income ÷ weighted average shares · filed 2014-03-04 | -$0.94 derived: net income ÷ weighted average shares · filed 2014-03-04 | -$1.30 derived: net income ÷ weighted average shares · filed 2014-03-04 | ||||
| 2011-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2014-03-04 | -$0.61 derived: net income ÷ weighted average shares · filed 2014-03-04 | -$0.97 derived: net income ÷ weighted average shares · filed 2014-03-04 | -$1.36 10-K · filed 2013-03-05 | ||||
| 2011-09-30 | -$0.25 10-Q · filed 2012-11-06 | -$0.61 derived: net income ÷ weighted average shares · filed 2013-03-05 | -$0.99 10-Q · filed 2012-11-06 | -$1.32 derived: net income ÷ weighted average shares · filed 2013-03-05 | ||||
| 2011-06-30 | -$0.37 10-Q · filed 2012-08-07 | -$0.76 10-Q · filed 2012-08-07 | -$1.10 derived: net income ÷ weighted average shares · filed 2013-03-05 | -$0.17 derived: net income ÷ weighted average shares · filed 2013-03-05 | ||||
| 2011-03-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2013-03-05 | -$0.73 derived: net income ÷ weighted average shares · filed 2013-03-05 | $0.24 derived: net income ÷ weighted average shares · filed 2013-03-05 | |||||
| 2010-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2013-03-05 | $0.64 derived: net income ÷ weighted average shares · filed 2013-03-05 | $0.73 10-K · filed 2013-03-05 | |||||
| 2010-09-30 | $0.97 10-Q · filed 2011-11-01 | $1.06 10-Q · filed 2011-11-01 | ||||||
| 2010-06-30 | $0.52 10-Q · filed 2011-08-02 | $0.09 10-Q · filed 2011-08-02 | ||||||
| 2009-12-31 | -$2.73 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |